Evaluating rituximab against cyclophosphamide or cyclosporine in idiopathic membranous nephropathy: a meta-analysis
Rituximab is comparable in efficacy to cyclophosphamide and cyclosporine for IMN treatment, with no significant difference in remission rates or severe adverse events. Treatment should be individualized.
Authors
- Yuping Huang (ORCID: https://orcid.org/0000-0003-4267-6108)
- Huimin Zhang (ORCID: https://orcid.org/0000-0002-7343-5641)
- Hong Chen (ORCID: https://orcid.org/0009-0004-5991-0372)
- Yin Zhang
Institutions
- Putian University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1186/s40001-025-03597-x
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43